CAR T-induced Immunotoxicity Webinar

In vivo Preclinical Efficacy & Safety of CAR-T, -NK, and -Myeloid Based Therapies

Evaluation of Safety and Efficacy of Antibody-based and CAR T Therapies in PBMC Humanized Mice

Presented by Jiwon Yang, Ph.D. - Senior Scientist, Innovation and Product Development, The Jackson Laboratory

A Novel In Vivo Model to Simultaneously Assess Efficacy and Toxicity of Chimeric Antigen Receptor T-Cell Immunotherapy

Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

This whitepaper examines the constraints and challenges inherent in each CAR T study type and how to overcome them with in vivo studies using fully humanized mouse models.

CRS Studies for CAR T Cell Therapy

Review JAX’s CRS evaluation capabilities and see how a CRS study can help move your CAR T therapeutic into the clinic faster, safer, and more confidently.